SCM
IDXX icon

Segantii Capital Management’s Idexx Laboratories IDXX Stock Holding History

Segantii Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,400
Closed -$638K – 380
2016
Q4 		$638K Sell
5,400
-8,100
-60% -$924K 0.18% 47
2016
Q3 		$1.51M Buy
+13,500
New +$1.42M 0.41% 41
2015
Q4 		– Sell
-18,436
Closed -$1.33M – 60
2015
Q3 		$1.33M Buy
+18,436
New +$1.32M 0.3% 50

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Segantii Capital Management's IDXX Position: Q1 2017 in Review

Segantii Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2017, closing a stake of 5,400 shares — an estimated $638K sold.

Segantii Capital Management first reported a position in IDXX in Q3 2015 and held it in 3 quarters. The position peaked at $1.51M in Q3 2016. 542 funds tracked by Wall St. Rank hold IDXX as of Q1 2017.

  • Segantii Capital Management reported no remaining Idexx Laboratories position as of Q1 2017 after selling out during the quarter.
  • Segantii Capital Management sold 5,400 Idexx Laboratories shares in Q1 2017, an estimated $638K.
  • Segantii Capital Management first reported a position in Idexx Laboratories in Q3 2015 and held it in 3 quarters.
  • Segantii Capital Management's Idexx Laboratories position peaked at $1.51M in Q3 2016.
  • 542 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2017.

Based on Segantii Capital Management's 13F filing for Q1 2017, filed 12 May 2017.